An integrated view of molecular changes, histopathology and outcomes in kidney transplants: Personal viewpoint

American Journal of Transplantation

Volumn 10, Issue 10, 2010, Pages 2223-2230

  Halloran, P F ^a,b   De Freitas, D G ^b   Einecke, G ^c   Famulski, K S ^b   Hidalgo, L G ^b   Mengel, M ^b,d   Reeve, J ^a   Sellares, J ^a   Sis, B ^a,c  

^a Division of Nephrology and Immunology   (Germany)

^b UNIVERSITY OF ALBERTA   (Canada)

^c HANNOVER MEDICAL SCHOOL   (Germany)

^d UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Antibody mediated rejection; kidney biopsies; microarrays; rejection; T cells; transplants

Indexed keywords

CALCINEURIN INHIBITOR; COMPLEMENT COMPONENT C4D; HLA ANTIBODY;

APOPTOSIS; ARTERY INTIMA PROLIFERATION; CELL DIFFERENTIATION; CLINICAL PROTOCOL; DISEASE COURSE; FIBROSIS; GLOMERULOPATHY; GRAFT FAILURE; GRAFT REJECTION; GRAFT SURVIVAL; HISTOPATHOLOGY; HLA SYSTEM; HUMAN; HYALINE DEGENERATION; KIDNEY BIOPSY; KIDNEY GRAFT; OUTCOME ASSESSMENT; PHENOTYPE; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; TIME; TREATMENT OUTCOME;

BIOPSY; COST OF ILLNESS; DISEASE PROGRESSION; FIBROSIS; GRAFT REJECTION; HUMANS; KIDNEY; KIDNEY TRANSPLANTATION; PATIENT COMPLIANCE; PHENOTYPE; TREATMENT OUTCOME;

EID: 77957196426     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2010.03268.x     Document Type: Review

References (37)

1. Halloran PF. Call for revolution: A new approach to describing allograft deterioration. Am J Transplant 2002 2: 195 200.
2. Meier-Kriesche HU, Schold JD, Srinivas TR, Kaplan B. Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era. Am J Transplant 2004 4: 378 383. (Pubitemid 38282293)
3. Solez K, Colvin RB, Racusen LC et al. Banff '05 Meeting report: Differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy ('CAN'). Am J Transplant 2007 7: 518 526. (Pubitemid 46376465)
4. Halloran PF, Langone AJ, Helderman JH, Kaplan B. Assessing long-term nephron loss: Is it time to kick the CAN grading system? Am J Transplant 2004 4: 1729 1730. (Pubitemid 39434427)
5. Mueller TF, Einecke G, Reeve J et al. Microarray analysis of rejection in human kidney transplants using pathogenesis-based transcript sets. Am J Transplant 2007 7: 2712 2722. (Pubitemid 350045779)
6. Halloran PF, de Freitas DG, Einecke G et al. The molecular phenotype of kidney transplants. Am J Transplant. In press.
7. Sis B, Jhangri G, Bunnag S, Allanach K, Kaplan B, Halloran PF. Endothelial gene expression in kidney transplants with alloantibody indicates antibody-mediated damage despite lack of C4d staining. Am J Transplant 2009 9: 2312 2323.
8. Furness PN, Taub N, Assmann KJ et al. International variation in histologic grading is large, and persistent feedback does not improve reproducibility. Am J Surg Pathol 2003 27: 805 810. (Pubitemid 36617518)
9. Yorukoglu K, Tuna B, Dikicioglu E et al. Reproducibility of the 1998 World Health Organization/International Society of Urologic Pathology classification of papillary urothelial neoplasms of the urinary bladder. Virchows Arch 2003 443: 734 740. (Pubitemid 38030626)
10. Einecke G, Reeve J, Sis B et al. A molecular classifier for predicting future graft loss in late kidney transplant biopsies. J Clin Invest 2010 120: 1862 1872.
11. Hidalgo LG, Campbell PM, Sis B et al. De novo donor specific antibody at the time of kidney transplant biopsy associates with microvascular pathology and late graft failure. Am J Transplant 2009 9: 2532 2541.
12. Halloran PF. T Cell mediated rejection of kidney transplants: A personal viewpoint. Am J Transplant 2010 10: 1126 1134.
13. Einecke G, Reeve J, Mengel M et al. Expression of B cell and immunoglobulin transcripts is a feature of inflammation in late allografts. Am J Transplant 2008 8: 1434 1443. (Pubitemid 351989485)
14. Mengel M, Reeve J, Bunnag S et al. Molecular correlates of scarring in kidney transplants: The emergence of mast cell transcripts. Am J Transplant 2009 9: 169 178.
15. Bunnag S, Allanach K, Jhangri GS et al. FOXP3 expression in human kidney transplant biopsies is associated with rejection and time post transplant but not with favorable outcomes. Am J Transplant 2008 8: 1423 1433. (Pubitemid 351989494)
16. Mueller TF, Reeve J, Jhangri GS et al. The transcriptome of the implant biopsy identifies donor kidneys at increased risk of delayed graft function. Am J Transplant 2008 8: 78 85.
17. Avihingsanon Y, Ma N, Pavlakis M et al. On the intraoperative molecular status of renal allografts after vascular reperfusion and clinical outcomes. J Am Soc Nephrol 2005 16: 1542 1548. (Pubitemid 41716461)
18. Rush D, Arlen D, Boucher A et al. Lack of benefit of early protocol biopsies in renal transplant patients receiving TAC and MMF: A randomized study. Am J Transplant 2007 7: 2538 2545. (Pubitemid 47561621)
19. Mengel M, Gwinner W, Schwarz A et al. Infiltrates in protocol biopsies from renal allografts. Am J Transplant 2007 7: 356 365. (Pubitemid 46096328)
20. Mengel M, Chapman JR, Cosio FG et al. Protocol biopsies in renal transplantation: Insights into patient management and pathogenesis. Am J Transplant 2007 7: 512 517. (Pubitemid 46376459)
21. Famulski KS, Einecke G, Sis B et al. Defining the canonical form of T-Cell-mediated rejection in human kidney transplants. Am J Transplant 2009 10: 810 820.
22. Mengel M, Bogers J, Bosmans JL et al. Incidence of C4d stain in protocol biopsies from renal allografts: Results from a multicenter trial. Am J Transplant 2005 5: 1050 1056. (Pubitemid 40571253)
23. Loupy A, Suberbielle-Boissel C, Hill GS et al. Outcome of subclinical antibody-mediated rejection in kidney transplant recipients with preformed donor-specific antibodies. Am J Transplant 2009 9: 2561 2570.
24. Gloor JM, Sethi S, Stegall MD et al. Transplant glomerulopathy: Subclinical incidence and association with alloantibody. Am J Transplant 2007 7: 2124 2132. (Pubitemid 47247042)
25. El Zoghby ZM, Stegall MD, Lager DJ et al. Identifying specific causes of kidney allograft loss. Am J Transplant 2009 9: 527 535.
26. Einecke G, Sis B, Reeve J et al. Antibody-mediated microcirculation injury is the major cause of late kidney transplant failure. Am J Transplant 2009 9: 2520 2531.
27. Everly MJ, Everly JJ, Arend LJ et al. Reducing de novo donor-specific antibody levels during acute rejection diminishes renal allograft loss. Am J Transplant 2009 9: 1063 1071.
28. Sis B, Einecke G, Chang J et al. Cluster analysis of lesions in kidney transplant biopsies: Microcirculation changes, tubulointerstitial inflammation, and scarring. Am J Transplant 2009 10: 421 430.
29. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med 2005 353: 487 497. (Pubitemid 41127293)
30. Gourishankar S, Leduc R, Connett J et al. Pathological and clinical characterization of the 'troubled transplant': Data from the DeKAF study. Am J Transplant 2010 10: 324 330.
31. Matas AJ, Leduc R, Rush D et al. Histopathologic clusters differentiate subgroups within the nonspecific diagnoses of CAN or CR: Preliminary data from the DeKAF study. Am J Transplant 2010 10: 315 323.
32. Hidalgo LG, Sis B, Sellares J et al. NK cell transcripts and NK cells in kidney biopsies from patients with donor-specific antibodies: Evidence for NK cell involvement in antibody-mediated rejection. Am J Transplant 2010 10: 1812 1822.
33. Reeve J, Einecke G, Mengel M et al. Diagnosing rejection in renal transplants: A comparison of molecular- and histopathology-based approaches. Am J Transplant 2009 9: 1802 1810.
34. Gloor JM, DeGoey SR, Pineda AA et al. Overcoming a positive crossmatch in living-donor kidney transplantation. Am J Transplant 2003 3: 1017 1023. (Pubitemid 36917550)
35. Famulski KS, Broderick G, Hay K et al. Transcriptome analysis reveals heterogeneity in the injury response of kidney transplants. Am J Transplant 2007 7: 2483 2495. (Pubitemid 47561622)
36. Humphreys BD, Lin SL, Kobayashi A et al. Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis. Am J Pathol 2010 176: 85 97.
37. Padrissa-Altes S, Zaouali MA, Franco-Gou R et al. Matrix metalloproteinase 2 in reduced-size liver transplantation: Beyond the matrix. Am J Transplant 2010 10: 1167 1177.